- Home
- NXN vs PASG Comparison
NXN vs PASG Comparison
Compare NXN & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXN
- PASG
- Stock Information
- Founded
- NXN 1992
- PASG 2017
- Country
- NXN United States
- PASG United States
- Employees
- NXN N/A
- PASG N/A
- Industry
- NXN Trusts Except Educational Religious and Charitable
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- NXN Finance
- PASG Health Care
- Exchange
- NXN Nasdaq
- PASG Nasdaq
- Market Cap
- NXN 45.5M
- PASG 42.2M
- IPO Year
- NXN N/A
- PASG 2020
- Fundamental
- Price
- NXN $11.79
- PASG $0.52
- Analyst Decision
- NXN
- PASG Strong Buy
- Analyst Count
- NXN 0
- PASG 3
- Target Price
- NXN N/A
- PASG $8.00
- AVG Volume (30 Days)
- NXN 9.7K
- PASG 138.4K
- Earning Date
- NXN 01-01-0001
- PASG 03-03-2025
- Dividend Yield
- NXN 4.23%
- PASG N/A
- EPS Growth
- NXN N/A
- PASG N/A
- EPS
- NXN 0.24
- PASG N/A
- Revenue
- NXN N/A
- PASG N/A
- Revenue This Year
- NXN N/A
- PASG N/A
- Revenue Next Year
- NXN N/A
- PASG N/A
- P/E Ratio
- NXN $48.42
- PASG N/A
- Revenue Growth
- NXN N/A
- PASG N/A
- 52 Week Low
- NXN $10.64
- PASG $0.45
- 52 Week High
- NXN $12.45
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- NXN 59.31
- PASG 39.73
- Support Level
- NXN $11.69
- PASG $0.52
- Resistance Level
- NXN $11.94
- PASG $0.60
- Average True Range (ATR)
- NXN 0.12
- PASG 0.05
- MACD
- NXN 0.01
- PASG 0.00
- Stochastic Oscillator
- NXN 54.82
- PASG 20.37
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.